Nutrients and Botanicals for Erectile Dysfunction: Examining the Evidence

Alternative Medicine Review

Volumn 9, Issue 1, 2004, Pages 4-16

  MacKay, Douglas ^a  

^a Thorne Research Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

'MACA'; ARGININE; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GINSENOSIDE; HERBACEOUS AGENT; LEPIDIUM MEYENII EXTRACT; NATURAL PRODUCT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PRASTERONE; PYCNOGENOL; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TRAZODONE; TRIBULUS TERRESTRIS EXTRACT; UNCLASSIFIED DRUG; YOHIMBINE;

AGITATION; ANTIOXIDANT ACTIVITY; CLINICAL PROTOCOL; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ERECTILE DYSFUNCTION; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; ISCHEMIC HEART DISEASE; LEPIDIUM MEYENII; MALE; MEDICAL LITERATURE; NUTRIENT; PATIENT SATISFACTION; PENIS ERECTION; PLANT ROOT; PUBLIC HEALTH; PUBLICATION; REVIEW; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SIDE EFFECT; SWEATING; TRIBULUS TERRESTRIS; UNITED STATES;

ARGININE; COMPLEMENTARY THERAPIES; DEHYDROEPIANDROSTERONE; GINKGO BILOBA; HUMANS; IMPOTENCE; LEPIDIUM; MALE; PANAX; PENILE ERECTION; PHYTOTHERAPY; TRIBULUS; YOHIMBINE;

EID: 1642412039     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Milsten R, Slowinsk J. The Sexual Male: Problems and Solutions. New York, NY: W.W. Norton and Company; 2000:1-5.
2. No authors listed. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
3. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
4. MacDonagh R, Ewings P, Porter T. The effect of erectile dysfunction on quality of life: psychometric testing of a new quality of life measure for patients with erectile dysfunction. J Urol 2002;167:212-217.
5. Goldstein I. Male sexual circuitry. Working Group for the Study of Central Mechanisms in Erectile Dysfunction. Sci Am 2000;283:70-75.
6. Nehra A, Kulaksizoglu H. Global perspectives and controversies in the epidemiology of male erectile dysfunction. Curr Opin Urol 2002;12:493-496.
7. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-1404.
8. Drewes SE, George J, Khan F. Recent findings on natural products with erectile-dysfunction activity. Phytochemistry 2003;62:1019-1025.
9. Wu G, Meininger CJ. Arginine nutrition and cardiovascular function. J Nutr 2000;130:2626-2629.
10. Bossaller C, Habib GB, Yamamoto H, et al. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987;79:170-174.
11. Chester AH, O'Neil GS, Moncada S, et al. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990;336:897-900.
12. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990;16:349-356.
13. Tanner FC, Noll G, Boulanger CM, Luscher TF. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 1991;83:2012-2020.
14. Gonzalez-Cadavid NF, Rajfer J. Therapeutic stimulation of penile nitric oxide synthase (NOS) and related pathways. Drugs Today (Barc) 2000;36:163-174.
15. Sullivan ME, Thompson CS, Dashwood MR, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999;43:658-665.
16. Kloner RA, Mullin SH, Shook T, et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol 2003;170:S46-S50.
17. Chitaley K, Webb RC, Mills TM. RhoA/Rho-kinase: a novel player in the regulation of penile erection. Int J Impot Res 2001;13:67-72.
18. Meuleman EJ. Prevalence of erectile dysfunction: need for treatment? Int J Impot Res 2002;14:S22-S28.
19. Lue TF. Erectile dysfunction. N Engl J Med 2000;342:1802-1813.
20. Anderson M, Nicholson B, Louie E, et al. An analysis of vasculogenic erectile dysfunction as a potential predictor of occult cardiac disease. J Urol 1998;159:30.
21. Greenstein A, Chen J, Miller H, et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997;9:123-126.
22. Zorgniotti AW, Lizza EF. Effect of large doses of the nitric oxide precursor, L-arginine, on erectile dysfunction. Int J Impot Res 1994;6:33-35.
23. Chen J, Wollman Y, Chemichovsky T, et al. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int 1999;83:269-273.
24. Fitzpatrick DF, Bing B, Rohdewald P. Endothelium-dependent vascular effects of Pycnogenol. J Cardiovasc Pharmacol 1998;32:509-515.
25. Stanislavov R, Nikolova V. Treatment of erectile dysfunction with pycnogenol and L-arginine. J Sex Marital Ther 2003;29:207-213.
26. Klotz T, Mathers MJ, Braun M, et al. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int 1999;63:220-223.
27. Simonsen U, Prieto D, Hernandez M, et al. Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries. J Urol 1997;157:2356-2360.
28. Morales A, Surridge DH, Marshall PG, Fenemore J. Nonhormonal pharmacological treatment of organic impotence. J Urol 1982;128:45-47.
29. Clark JT, Smith ER, Davidson JM. Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male rats. Neuroendocrinology 1985;41:36-43.
30. Morales A, Condra M, Owen JA, et al. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 1987;137:1168-1172.
31. Reid K, Surridge DH, Morales A, et al. Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet 1987;2:421-423.
32. Vogt HJ, Brandl P, Kockott G, et al. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impot Res 1997;9:155-161.
33. Mann K, Klingler T, Noe S, et al. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch Sex Behav 1996;25:1-16.
34. Guirguis WR. Oral treatment of erectile dysfunction: from herbal remedies to designer drugs. J Sex Marital Ther 1998;24:69-73.
35. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998;159:433-436.
36. Riley AJ, Goodman R, Kellet JM, Orr R. Double-blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sex Marital Ther 1989;4:17-22.
37. Susset JG, Tessier CD, Wincze J, et al. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol 1989;141:1360-1363.
38. Morales A. Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed? World J Urol 2001;19:251-255.
39. Riley AJ. Yohimbine in the treatment of erectile disorder. Br J Clin Pract 1994;48:133-136.
40. Bratman S, Girman A. Mosby's Handbook of Herbs and Supplements and their Therapeutic Uses. St Louis, MO: Mosby Inc; 2003:976-978.
41. Lebret T, Herve JM, Gorny P, et al. Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur Urol 2002;41:608-613.
42. Nocerino E, Amato M, Izzo AA. The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 2000;71:S1-S5.
43. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997;54:1-8.
44. Tamaoki J, Nakata J, Kawatani K, et al. Ginsenoside-induced relaxation of human bronchial smooth muscle via release of nitric oxide. Br J Pharmacol 2000;130:1859-1864.
45. Han SW, Kim H. Ginsenosides stimulate endogenous production of nitric oxide in rat kidney. Int J Biochem Cell Biol 1996;28:573-580.
46. Choi YD, Rha KH, Choi HK. In vitro and in vivo experimental effect of Korean red ginseng on erection. J Urol 1999;162:1508-1511.
47. Choi YD, Xin ZC, Choi HK. Effect of Korean red ginseng on the rabbit corpus cavemosal smooth muscle. Int J Impot Res 1998;10:37-43.
48. Kim HJ, Woo DS, Lee G, Kim JJ. The relaxation effects of ginseng saponin in rabbit corporal smooth muscle: is it a nitric oxide donor? Br J Urol 1998;82:744-748.
49. Chen X, Lee TJ. Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavemosum. Br J Pharmacol 1995;115:15-18.
50. Choi HK, Seong DH, Rha KH. Clinical efficacy of Korean red ginseng for erectile dysfunction. Int J Impot Res 1995;7:181-186.
51. Hong B, Ji YH, Hong JH, et al. A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol 2002;168:2070-2073.
52. Rowland DL, Tai W. A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions. J Sex Marital Ther 2003;29:185-205.
53. Zheng BL, He K, Kim CH, et al. Effect of a lipidic extract from Lepidium meyenii on sexual behavior in mice and rats. Urology 2000;55:598-602.
54. Cicero AF, Piacente S, Plaza A, et al. Hexanic maca extract improves rat sexual performance more effectively than methanolic and chloroformic maca extracts. Andrologia 2002;34:177-179.
55. Cicero AF, Bandieri E, Arletti R. Lepidium meyenii Walp. improves sexual behaviour in male rats independently from its action on spontaneous locomotor activity. J Ethnopharmacol 2001;75:225-229.
56. Gonzales GF, Cordova A, Vega K, et al. Effect of Lepidium meyenii (maca) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia 2002;34:367-372.
57. Gonzales GF, Cordova A, Vega K, et al. Effect of Lepidium meyenii (maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. J Endocrinol 2003;176:163-168.
58. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998;24:139-143.
59. McKenna K. The brain is the master organ in sexual function: central nervous system control of male and female sexual function. Int J Impot Res 1999;11:S48-S55.
60. Wheatley D. Ginkgo biloba in the treatment of sexual function due to antidepressant drugs. Human Psychopharmacol 1999;14:512-513.
61. Ashton AK, Ahrens K, Gupta S, Masand PS. Antidepressant-induced sexual dysfunction and Ginkgo biloba. Am J Psychiatry 2000;157:836-837.
62. Kang BJ, Lee SJ, Kim MD, Cho MJ. A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol 2002;17:279-284.
63. Marcocci L, Maguire JJ, Droy-Lefaix MT, Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 1994;201:748-755.
64. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992;340:1136-1139.
65. Chen X, Salwinski S, Lee TJ. Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway. Clin Exp Pharmacol Physiol 1997;24:958-959.
66. Auguet M, DeFeudis FV, Clostre F. Effects of Ginkgo biloba on arterial smooth muscle responses to vasoactive stimuli. Gen Pharmacol 1982;13:169-171.
67. Auguet M, DeFeudis FV, Clostre F, Deghenghi R. Effects of an extract of Ginkgo biloba on rabbit isolated aorta. Gen Pharmacol 1982;13:225-230.
68. Auguet M, Clostre F. Effects of an extract of Ginkgo biloba and diverse substances on the phasic and tonic components of the contraction of an isolated rabbit aorta. Gen Pharmacol 1983;14:277-280.
69. Paick JS, Lee JH. An experimental study of the effect of Ginkgo biloba extract on the human and rabbit corpus cavemosum tissue. J Urol 1996;156:1876-1880.
70. Salvini S, Stampfer MJ, Barbieri RL, Hennekens CH. Effects of age, smoking and vitamins on plasma DHEAS levels: a cross-sectional study in men. J Clin Endocrinol Metab 1992;74:139-143.
71. Reiter WJ, Pycha A, Schatzl G, et al. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology 1999;53:590-594.
72. Adimoelja A. Phytochemicals and the break-through of traditional herbs in the management of sexual dysfunctions. Int J Androl 2000;23:82-84.
73. Adimoelja A, Adaikan PG. Protodioscin from herbal plant Tribulus terrestris L. improves male sexual functions possibly via DHEA. Int J Impot Res 1997;9:S64.
74. Bardin CW, Swerdloff RS, Santen RJ. Androgens: risks and benefits. J Clin Endocrinol Metab 1991;73:4-7.
75. Adaikan PG, Gauthaman K, Prasad RN, Ng SC. Proerectile pharmacological effects of Tribulus terrestris extract on the rabbit corpus cavemosum. Ann Acad Med Singapore 2000;29:22-26.
76. Gauthaman K, Ganesan AP, Prasad RN. Sexual effects of puncturevine (Tribulus terrestris) extract (protodioscin): an evaluation using a rat model. J Altern Complement Med 2003;9:257-265.